BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14601636)

  • 1. The quest for a tumor suppressor gene phenotype.
    Presneau N; Manderson EN; Tonin PN
    Curr Mol Med; 2003 Nov; 3(7):605-29. PubMed ID: 14601636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
    Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
    Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ever since Knudson.
    Devilee P; Cleton-Jansen AM; Cornelisse CJ
    Trends Genet; 2001 Oct; 17(10):569-73. PubMed ID: 11585662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
    Cody NA; Ouellet V; Manderson EN; Quinn MC; Filali-Mouhim A; Tellis P; Zietarska M; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Oncogene; 2007 Jan; 26(4):618-32. PubMed ID: 16909122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor suppressors--genes and proteins].
    Lothe RA; Blomhoff HK
    Tidsskr Nor Laegeforen; 1998 May; 118(12):1887-92. PubMed ID: 9638059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
    Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
    Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview.
    Wang LH; Wu CF; Rajasekaran N; Shin YK
    Cell Physiol Biochem; 2018; 51(6):2647-2693. PubMed ID: 30562755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
    Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
    Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
    Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
    Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor loci in bladder cancer.
    Knowles MA
    Front Biosci; 2007 Jan; 12():2233-51. PubMed ID: 17127460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent somatic gene conversion as a mechanism for loss of heterozygosity in tumor suppressor genes.
    Takahashi KK; Innan H
    Genome Res; 2022 Jun; 32(6):1017-1025. PubMed ID: 35618418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.